Compounds > diphenylamine
Page last updated: 2024-08-21

diphenylamine and Neurilemmoma

diphenylamine has been researched along with Neurilemmoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berry, P; Chikobava, L; Fischer-Huchzermeyer, S; Harder, A; Mautner, VF; Senner, V; Stahn, V; Veal, GJ; Zangarini, M1
Anderson, LK; Collins, MH; Greeley, AD; Halfond, AL; Keng, VW; Largaespada, DA; Moertel, CL; Powell, NM; Rahrmann, EP; Ratner, N; Rizvi, T; Watson, AL1
Burga, RA; Fernandes, R; Li, C; Sweeney, EE; Zhu, Y1

Other Studies

3 other study(ies) available for diphenylamine and Neurilemmoma

ArticleYear
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.
    BMC research notes, 2018, Jul-28, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzamides; Diphenylamine; Heterografts; Humans; Mice; Mice, Nude; Nerve Sheath Neoplasms; Neurilemmoma; Sarcoma

2018
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.
    Oncotarget, 2014, Mar-30, Volume: 5, Issue:6

    Topics: Animals; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Diphenylamine; Disease Models, Animal; Drug Synergism; Everolimus; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neoplasm Grading; Neurilemmoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Schwann Cells; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2014
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Scientific reports, 2016, 11-11, Volume: 6

    Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Ferrocyanides; Hyperthermia, Induced; Infrared Rays; Laser Therapy; MAP Kinase Kinase Kinases; Mice; Nanoparticles; Neoplasm Proteins; Neurilemmoma; Neurofibromatosis 1; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Surface Plasmon Resonance

2016